T Cell News and Research

Latest T Cell News and Research

U.S. research challenges Bush over embryonic stem-cell research

Researchers in the U.S. appear all set to challenge President Bush's stand over the issue of embryonic stem-cell research.

24 Aug 2006

New methods for screening nanoparticles and interaction with human cells

Scientists have developed a screening method to examine how newly made nanoparticles - particles with dimensions on the order of billionths of a meter - interact with human cells following exposure for various times and doses.

21 Aug 2006

Dual-mode nanoscale imaging yields new details of cellular events

To create drugs capable of targeting malignancies, scientists must first decode exactly how a cell or a group of cells communicates with other cells and reacts to a broad spectrum of complex biomolecules surrounding it.

21 Aug 2006

Targeted magnetic nanoparticles may be useful in both detecting and treating metastatic breast cancer

An in-depth study of nanoparticle distribution in tumor-bearing mice has shown that targeted magnetic nanoparticles accumulate and cluster in both primary breast tumors and metastatic lesions that have developed in the lung.

21 Aug 2006

St. John's wort and polymeric nanoparticles to treat ovarian tumors using light

By combining a compound produced by the plant St. John's wort with polymeric nanoparticles, researchers at the University of Geneva in Switzerland have developed a promising method for treating ovarian tumors using light.

21 Aug 2006

'Switch' may turn off immune cells that fight HIV

An international research team believe they have discovered why the immune system is unable to control HIV infection.

20 Aug 2006

Bladder urothelium in PBS/IC shows distinct differences in keratin profiles

Research groups from the Netherlands and Denmark led by Pilar Laguna studied urothelial involvement in PBS/IC by characterizing the keratin phenotype of bladder urothelium in 18 patients with the disorder.

20 Aug 2006

A tissue marker of poor prognosis in clear cell renal cell carcinoma

The search for molecular markers that further advance our knowledge of the biology of renal cell carcinoma (RCC) and assist in evaluating the diagnosis and prognosis of patients remains the subject of intense investigation.

20 Aug 2006

Chink in the armour of H5N1 bird flu virus

British scientists say they have made a breakthrough in their development of a bird flu drug that could treat humans in the event of an outbreak.

20 Aug 2006

Pomegranate juice may decrease PSA progression in patients with cancer recurrence after treatment

Because of their high content of antioxidants, pomegranate juice is frequently recommended for cancer prevention and overall wellness. While small studies have suggested a role against prostate carcinogenesis, no organized trials have been published until now.

17 Aug 2006

Appointee to head National Cancer Institute discusses research funding cuts

John Niederhuber, a surgeon whom President Bush on Tuesday appointed as National Cancer Institute director, on Wednesday said that he hopes to find new nontoxic cancer medications but added that the agency likely will have to eliminate some programs because of budgetary issues, the New York Times reports.

17 Aug 2006

Study: Collecting duct carcinoma

Collecting duct carcinoma is a rare and highly aggressive variant of renal cell carcinoma that frequently presents with advanced disease, has few effective treatment options, and is associated with a poor prognosis.

17 Aug 2006

FDA approves Plavix for STEMI heart attacks

The Food and Drug Administration (FDA) today approved the use of Plavix (clopidogrel bisulfate) for patients who have had a type of heart attack called acute ST-segment elevation myocardial infarction (STEMI), who are not going to have coronary artery repair (angioplasty).

17 Aug 2006

The endocannabinoid system controls key epileptogenic circuits in the hippocampus

The same brain machinery that responds to the active substance in marijuana provides a central "on-demand" protection against seizures, researchers have found. They said their discoveries suggest that the "endocannabinoid" system might constitute a prime target for drugs against seizures of epilepsy and other neurodegenerative diseases.

16 Aug 2006

Chemotherapy and breast cancer - side effects underestimated

Researchers believe that the side effects of chemotherapy treatment for breast cancer are probably higher than thought.

16 Aug 2006

RNA gene found to be one of the fastest evolving regions in human genome

Since completing the sequencing of the chimpanzee genome last year, geneticists have spent many hours comparing human DNA sequences to those of our closest evolutionary relative, looking for the differences that distinguish the two species.

16 Aug 2006

Genotoxic bacteria in the digestive tract

Escherichia coli is a commensal bacterium, which lives peacefully in our digestive tract. However, certain strains are pathogenic and are frequently incriminated in a broad spectrum of infections, affecting both farmed animals and humans (diarrhoea, urinary tract infections, food poisoning, septicaemia, neonatal meningitis, etc.).

16 Aug 2006

Trying to improve on the activity of Interferon-Alpha in metastatic renal cell carcinoma

Interferon-alpha (IFN) has been a mainstay in the systemic treatment of metastatic renal cell carcinoma (RCC) for decades, with response rates ranging from 3-15%.

16 Aug 2006

Serious gaps in Indian public knowledge about HIV

As India gears up implementation of national plans to fight HIV, infectious diseases experts at Johns Hopkins and elsewhere are pointing out serious gaps in public knowledge about the disease and identifying early problems in private clinics, where 70 percent of HIV-infected Indians receive their everyday medical care.

15 Aug 2006

Major new research grant to develop new technology for delivering cell-by-cell medical treatments

Scientists from the Universities of Dundee and St Andrews have won a major new research grant to develop a completely new technology for delivering cell-by-cell medical treatments.

15 Aug 2006

T Cell News and Research

Latest T Cell News and Research

U.S. research challenges Bush over embryonic stem-cell research

New methods for screening nanoparticles and interaction with human cells

Dual-mode nanoscale imaging yields new details of cellular events

Targeted magnetic nanoparticles may be useful in both detecting and treating metastatic breast cancer

St. John's wort and polymeric nanoparticles to treat ovarian tumors using light

'Switch' may turn off immune cells that fight HIV

Bladder urothelium in PBS/IC shows distinct differences in keratin profiles

A tissue marker of poor prognosis in clear cell renal cell carcinoma

Chink in the armour of H5N1 bird flu virus

Pomegranate juice may decrease PSA progression in patients with cancer recurrence after treatment

Appointee to head National Cancer Institute discusses research funding cuts

Study: Collecting duct carcinoma

FDA approves Plavix for STEMI heart attacks

The endocannabinoid system controls key epileptogenic circuits in the hippocampus

Chemotherapy and breast cancer - side effects underestimated

RNA gene found to be one of the fastest evolving regions in human genome

Genotoxic bacteria in the digestive tract

Trying to improve on the activity of Interferon-Alpha in metastatic renal cell carcinoma

Serious gaps in Indian public knowledge about HIV

Major new research grant to develop new technology for delivering cell-by-cell medical treatments

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in